Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP

Table 3

The baseline characteristics of HCM patients.

(a)

Mean age
Males/females	33/31
The ICD implantation	8 patients
EF %
hsTnI value
Medications	Patients
Beta-blockers	43
Verapamil	17
Diuretics	3
ACE inhibitors	4
Past history of AP in years

(b)

		Total ()	Subgroup 0 ()	Subgroup 1 ()	Subgroup 2 ()
Baseline characteristics of subgroups of patients with HCM
NYHA	Class I ( (%))	12 (19%)	9 (24%)	3 (25%)	0^,
	Class II ( (%))	33 (51%)	20 (52%)	6 (50%)	7 (50%)
	Class III ( (%))	19 (30%)	9 (24%)	3 (25%)	7 (50%)
CCS	Class I ( (%))	24 (38%)	18 (47%)	5 (42%)	1 (7%)^,
	Class II ( (%))	29 (45%)	16 (42%)	5 (42%)	8 (57%)
	Class III ( (%))	11 (17%)	4 (11%)	2 (8%)	5 (36%)
Syncope ( (%))		25 (39%)	13 (34%)	5 (42%)	7 (50%)
Sudden death in family history ( (%))		23 (36%)	14 (37%)	4 (33%)	5 (36%)
All patients had Holter
NSVT in Holter ( (%))		26 (41%)	15 (39%)	5 (42%)	6 (43%)
LV maximal wall thickness (LVMWT) at diastole (cm)			Detailed calculation in Figure 3
Resting LVOT gradient, ≥30 mmHg ( (%))		14 (22%)	6 (16%)	3 (25%)	5 (36%)
Provocable LVOT gradient, ≥30 mmHg ( (%))		14 (22%)	5 (13%)	3 (25%)	6 (43%)
Left atrial diameter (cm)			Detailed calculation in Figure 5

Abbreviations: CCS: Canadian Cardiovascular Society; LVOT: left ventricular outflow tract; LV: left ventricular; NSVT: nonsustained ventricular tachycardia; NYHA: New York Heart Association. subgroup 0 vs. 2; subgroup 1 vs. 2.